# Neogenomics Inc: Form DEF 14A, filed Apr 8, 2024

- Company: [Neogenomics Inc](/companies/neo.md) (CIK 1077183)
- Form: DEF 14A
- Filed: 2024-04-08
- Accepted by EDGAR: Apr 8, 2024, 20:06 ET
- Period: 2023-12-31
- Accession: 0001077183-24-000042
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1077183/000107718324000042/neo-20240408.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1077183/000107718324000042/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1077183/000107718324000042/neo-20240408.htm

Filed Apr 8, 2024.
Source: SEC EDGAR, the filing index for accession 0001077183-24-000042. Last ingested by Listed: Oct 24, 2026, 15:02 ET. No prices; not investment advice.
